NAION
-

FDA Orders Vision Warning Labels for GLP-1 Medications
The US Food and Drug Administration has ordered manufacturers of GLP-1 drugs to update product labels with warnings regarding a rare eye condition.
-

Todd Engel Files Lawsuit After Ozempic Use Precedes Vision Loss
Maryland resident Todd Engel has filed a lawsuit against Novo Nordisk after suffering permanent vision loss in both eyes following Ozempic use.
